raymond james financial inc (RJF) Key Developments
Raymond James Financial, Inc. Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 05:00 PM
Feb 22 15
Raymond James Financial, Inc. Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 05:00 PM. Venue: The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St, 40th Floor (D Elevator Bank), New York, NY10007, United States. Speakers: Stuart Barich, Managing Director.
Todd Barnes Joins Raymond James’s Public Finance Group as an Atlanta-Based Managing Director
Feb 18 15
Raymond James announced that Todd Barnes has joined the firm’s Public Finance group as an Atlanta-based managing director focusing primarily on issuers in Georgia and South Carolina. Barnes joins Raymond James from Robert W. Baird & Co. where he was managing director and manager of the Southeastern region for public finance.
Raymond James Financial Mulls Acquisitions
Jan 22 15
Raymond James Financial, Inc. (NYSE:RJF) is looking for acquisitions. Chief Executive Officer, Paul Reilly said, “We still have capital to employ. We're still looking at acquisitions. We're very disciplined. I've said before, we've looked at a lot of them and if we can't, if they're not the right fit and certainly, first, culture, secondly, strategic, and third is price. We've had a number of conversations where price hasn't worked so we still think we can employ capital, but we're very disciplined, which people should feel happy with. If we think we truly have excess capital we can't use, we'll look at alternatives of deploying it. At this state, we think we can use our capital wisely.”
Raymond James Financial, Inc. - Shareholder/Analyst Call
Jan 21 15
2015 annual shareholders’ meeting
Raymond James Financial, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2014
Jan 21 15
Raymond James Financial, Inc. reported unaudited consolidated earnings results for the first quarter ended December 31, 2014. For the quarter, the company reported total revenue of $1,279,844,000 against $1,208,774,000 a year ago. Net revenue was $1,252,460,000 against $1,183,402,000 a year ago. Net income attributable to the company was $126,296,000 or $0.87 per diluted share against $116,633,000 or $0.81 per diluted share a year ago. Pre-tax income of $202,908,000 compared to $178,924,000 a year ago. Return on equity was 12.0% compared to 12.5% a year ago. On non-GAAP basis, tangible book value per share was $27.71 against $24.57 a year ago.